10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Antimicrobial Chemotherapy plays a pivotal role in combating bacterial, viral, fungal, and parasitic infections, offering a diverse arsenal of agents to thwart microbial growth. Antibiotics, the cornerstone of antimicrobial therapy, target bacterial organisms by disrupting crucial cellular processes or structures. These agents can be classified into various categories, including beta-lactams, tetracyclines, macrolides, and fluoroquinolones, each with unique mechanisms of action. In addition to antibiotics, antiviral drugs are instrumental in managing viral infections. These medications often interfere with the virus's replication cycle, preventing its spread within the host. Antifungal and antiparasitic agents further broaden the spectrum of antimicrobial therapy, addressing mycoses and parasitic diseases. However, the widespread use of antimicrobials has led to the emergence of drug-resistant strains, posing a global health challenge. This underscores the importance of judicious and responsible use of antimicrobial agents to preserve their efficacy and mitigate the development of resistance.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States